Literature DB >> 26595185

Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.

Sadaf Mutahir1, Jakub Jończyk2, Marek Bajda2, Islam Ullah Khan3, Muhammad Asim Khan1, Nisar Ullah4, Muhammad Ashraf5, Sadaf Riaz1, Sajjad Hussain1, Muhammad Yar6.   

Abstract

A series of new biphenyl bis-sulfonamide derivatives 2a-3p were synthesized in good to excellent yield (76-98%). The inhibitory potential of the synthesized compounds on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) was investigated. Most of the screened compounds showed modest in vitro inhibition for both AChE and BChE. Compared to the reference compound eserine (IC50 0.04 ± 0.0001 μM for AChE) and (IC50 0.85 ± 0.0001 μM for BChE), the IC50 values of these compounds were ranged from 2.27 ± 0.01 to 123.11 ± 0.04 μM for AChE and 7.74 ± 0.07 to <400 μM for BuChE. Among the tested compounds, 3p was found to be the most potent against AChE (IC50 2.27 ± 0.01 μM), whereas 3g exhibited the highest inhibition for BChE (IC50 7.74 ± 0.07 μM). Structure-activity relationship (SAR) of these compounds was developed and elaborated with the help of molecular docking studies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer’s disease; Biphenyl sulfonamides; Butyrylcholinesterase

Mesh:

Substances:

Year:  2015        PMID: 26595185     DOI: 10.1016/j.bioorg.2015.11.002

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  7 in total

1.  Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors.

Authors:  Nebih Lolak; Süleyman Akocak; Mustafa Durgun; Hatice Esra Duran; Adem Necip; Cüneyt Türkeş; Mesut Işık; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-09-22       Impact factor: 3.364

2.  Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies.

Authors:  Shabnam Shahzad; Muhammad Abdul Qadir; Mahmood Ahmed; Saghir Ahmad; Muhammad Jadoon Khan; Asad Gulzar; Muhammad Muddassar
Journal:  RSC Adv       Date:  2020-11-25       Impact factor: 4.036

3.  Novel biphenyl ester derivatives as tyrosinase inhibitors: Synthesis, crystallographic, spectral analysis and molecular docking studies.

Authors:  Huey Chong Kwong; C S Chidan Kumar; Siau Hui Mah; Tze Shyang Chia; Ching Kheng Quah; Zi Han Loh; Siddegowda Chandraju; Gin Keat Lim
Journal:  PLoS One       Date:  2017-02-27       Impact factor: 3.240

4.  Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.

Authors:  Zeynep Soyer; Sirin Uysal; Sulunay Parlar; Ayse Hande Tarikogullari Dogan; Vildan Alptuzun
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-21       Impact factor: 5.051

Review 5.  Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review.

Authors:  Chuang Zhao; K P Rakesh; L Ravidar; Wan-Yin Fang; Hua-Li Qin
Journal:  Eur J Med Chem       Date:  2018-11-22       Impact factor: 6.514

6.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

7.  Selective Arylation of 2-Bromo-4-chlorophenyl-2-bromobutanoate via a Pd-Catalyzed Suzuki Cross-Coupling Reaction and Its Electronic and Non-Linear Optical (NLO) Properties via DFT Studies.

Authors:  Usman Nazeer; Nasir Rasool; Aqsa Mujahid; Asim Mansha; Muhammad Zubair; Naveen Kosar; Tariq Mahmood; Ali Raza Shah; Syed Adnan Ali Shah; Zainul Amiruddin Zakaria; Muhammad Nadeem Akhtar
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.